Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Different virulence of candida albicans is attributed to the ability of escape from neutrophil extracellular traps by secretion of DNase.

Zhang X, Zhao S, Sun L, Li W, Wei Q, Ashman RB, Hu Y.

Am J Transl Res. 2017 Jan 15;9(1):50-62. eCollection 2017.

2.

An atypical role for the myeloid receptor Mincle in central nervous system injury.

Arumugam TV, Manzanero S, Furtado M, Biggins PJ, Hsieh YH, Gelderblom M, MacDonald KP, Salimova E, Li YI, Korn O, Dewar D, Macrae IM, Ashman RB, Tang SC, Rosenthal NA, Ruitenberg MJ, Magnus T, Wells CA.

J Cereb Blood Flow Metab. 2017 Jun;37(6):2098-2111. doi: 10.1177/0271678X16661201. Epub 2016 Jan 1.

3.

Mincle polarizes human monocyte and neutrophil responses to Candida albicans.

Vijayan D, Radford KJ, Beckhouse AG, Ashman RB, Wells CA.

Immunol Cell Biol. 2012 Oct;90(9):889-95. doi: 10.1038/icb.2012.24. Epub 2012 May 29.

PMID:
22641025
4.
5.

Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.

Li Wq, Hu Xc, Zhang X, Ge Y, Zhao S, Hu Y, Ashman RB.

Vaccine. 2011 Jul 26;29(33):5526-33. doi: 10.1016/j.vaccine.2011.05.030. Epub 2011 Jun 7.

PMID:
21645574
6.

IL-12 and related cytokines: function and regulatory implications in Candida albicans infection.

Ashman RB, Vijayan D, Wells CA.

Clin Dev Immunol. 2011;2011:686597. doi: 10.1155/2011/686597. Epub 2010 Nov 1. Review.

7.

Gene targeting demonstrates that inducible nitric oxide synthase is not essential for resistance to oral candidiasis in mice, or for killing of Candida albicans by macrophages in vitro.

Farah CS, Saunus JM, Hu Y, Kazoullis A, Ashman RB.

Oral Microbiol Immunol. 2009 Feb;24(1):83-8. doi: 10.1111/j.1399-302X.2008.00462.x.

PMID:
19121076
8.

Human and mouse macrophage-inducible C-type lectin (Mincle) bind Candida albicans.

Bugarcic A, Hitchens K, Beckhouse AG, Wells CA, Ashman RB, Blanchard H.

Glycobiology. 2008 Sep;18(9):679-85. doi: 10.1093/glycob/cwn046. Epub 2008 May 28.

PMID:
18509109
9.

Protective and pathologic immune responses against Candida albicans infection.

Ashman RB.

Front Biosci. 2008 May 1;13:3334-51. Review.

PMID:
18508436
10.

The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans.

Wells CA, Salvage-Jones JA, Li X, Hitchens K, Butcher S, Murray RZ, Beckhouse AG, Lo YL, Manzanero S, Cobbold C, Schroder K, Ma B, Orr S, Stewart L, Lebus D, Sobieszczuk P, Hume DA, Stow J, Blanchard H, Ashman RB.

J Immunol. 2008 Jun 1;180(11):7404-13.

11.

New rod-plate anterior instrumentation for thoracolumbar/lumbar scoliosis: biomechanical evaluation compared with dual-rod and single-rod with structural interbody support.

Zhang H, Johnston CE 2nd, Pierce WA, Ashman RB, Bronson DG, Haideri NF.

Spine (Phila Pa 1976). 2006 Dec 1;31(25):E934-40.

PMID:
17139209
12.

Effector function of leucocytes from susceptible and resistant mice against distinct isolates of Candida albicans.

Hu Y, Farah CS, Ashman RB.

Immunol Cell Biol. 2006 Oct;84(5):455-60. Epub 2006 Jul 20.

PMID:
16869942
13.

Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting.

Farah CS, Hu Y, Riminton S, Ashman RB.

Oral Microbiol Immunol. 2006 Aug;21(4):252-5.

PMID:
16842510
14.

Isolates of Candida albicans that differ in virulence for mice elicit strain-specific antibody-mediated protective responses.

Hu Y, Farah CS, Ashman RB.

Microbes Infect. 2006 Mar;8(3):612-20. Epub 2006 Jan 5.

PMID:
16503182
15.

Active and passive immunization against oral Candida albicans infection in a murine model.

Farah CS, Ashman RB.

Oral Microbiol Immunol. 2005 Dec;20(6):376-81.

PMID:
16238599
16.

Modulation of the antibody response by Porphyromonas gingivalis and Fusobacterium nucleatum in a mouse model.

Gemmell E, Bird PS, Ford PJ, Ashman RB, Gosling P, Hu Y, Seymour GJ.

Oral Microbiol Immunol. 2004 Aug;19(4):247-51.

PMID:
15209995
17.

Innate versus adaptive immunity in Candida albicans infection.

Ashman RB, Farah CS, Wanasaengsakul S, Hu Y, Pang G, Clancy RL.

Immunol Cell Biol. 2004 Apr;82(2):196-204.

PMID:
15061774
18.
19.

Differences in mouse strain influence leukocyte and immunoglobulin phenotype response to Porphyromonas gingivalis.

Gemmell E, Winning TA, Carter CL, Ford PJ, Bird PS, Ashman RB, Grieco DA, Seymour GJ.

Oral Microbiol Immunol. 2003 Dec;18(6):364-70.

PMID:
14622342
20.

Role of complement C5 and T lymphocytes in pathogenesis of disseminated and mucosal candidiasis in susceptible DBA/2 mice.

Ashman RB, Papadimitriou JM, Fulurija A, Drysdale KE, Farah CS, Naidoo O, Gotjamanos T.

Microb Pathog. 2003 Feb;34(2):103-13.

PMID:
12623278
21.

Cytokines in the oral mucosa of mice infected with Candida albicans.

Farah CS, Gotjamanos T, Seymour GJ, Ashman RB.

Oral Microbiol Immunol. 2002 Dec;17(6):375-8.

PMID:
12485329
22.

Nitric oxide-enhanced resistance to oral candidiasis.

Elahi S, Pang G, Ashman RB, Clancy R.

Immunology. 2001 Dec;104(4):447-54.

23.

Primary role for CD4(+) T lymphocytes in recovery from oropharyngeal candidiasis.

Farah CS, Elahi S, Drysdale K, Pang G, Gotjamanos T, Seymour GJ, Clancy RL, Ashman RB.

Infect Immun. 2002 Feb;70(2):724-31.

24.

Irradiation-induced oral candidiasis in an experimental murine model.

Farah CS, Hong S, Wanasaengsakul S, Elahi S, Pang G, Gotjamanos T, Seymour GJ, Clancy RL, Ashman RB.

Oral Microbiol Immunol. 2001 Dec;16(6):358-63.

PMID:
11737659
25.

T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis.

Farah CS, Elahi S, Pang G, Gotjamanos T, Seymour GJ, Clancy RL, Ashman RB.

Infect Immun. 2001 Oct;69(10):6110-8.

26.

Stability of external circular fixation: a multi-variable biomechanical analysis.

Bronson DG, Samchukov ML, Birch JG, Browne RH, Ashman RB.

Clin Biomech (Bristol, Avon). 1998 Sep;13(6):441-448.

PMID:
11415819
27.

Mechanical testing of a single rod versus a double rod in a long-segment animal model.

Wattenbarger JM, Herring JA, Bronson D, Ashman RB.

J Spinal Disord. 2001 Jun;14(3):232-6.

PMID:
11389374
28.

Oral candidosis.

Farah CS, Ashman RB, Challacombe SJ.

Clin Dermatol. 2000 Sep-Oct;18(5):553-62. Review. No abstract available.

PMID:
11134850
29.

Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis.

Elahi S, Pang G, Clancy R, Ashman RB.

Infect Immun. 2000 Oct;68(10):5771-7.

30.

Role of Fas/FasL in systemic candidiasis.

Ashman RB, Mullbacher A, Papadimitriou JM.

J Infect Dis. 2000 Jun;181(6):2118-20. No abstract available.

PMID:
10837210
31.

Acute susceptibility of aged mice to infection with Candida albicans.

Ashman RB, Papadimitriou JM, Fulurija A.

J Med Microbiol. 1999 Dec;48(12):1095-102.

PMID:
10591163
32.

Both CD4+ and CD8+ lymphocytes reduce the severity of tissue lesions in murine systemic cadidiasis, and CD4+ cells also demonstrate strain-specific immunopathological effects.

Ashman RB, Fulurija A, Papadimitriou JM.

Microbiology. 1999 Jul;145 ( Pt 7):1631-1640. doi: 10.1099/13500872-145-7-1631.

PMID:
10439402
33.

Complement-mediated regulation of Trichomonas vaginalis infection in mice.

Caterina P, Lynch D, Ashman RB, Warton A, Papadimitriou JM.

Exp Clin Immunogenet. 1999;16(2):107-16.

PMID:
10343161
34.

Type 1 and type 2 cytokines: from basic science to fungal infections.

Murphy JW, Bistoni F, Deepe GS, Blackstock RA, Buchanan K, Ashman RB, Romani L, Mencacci A, Cenci E, Fè d'Ostiani C, Del Sero G, Calich VL, Kashino SS.

Med Mycol. 1998;36 Suppl 1:109-18. Review.

PMID:
9988499
35.
36.
37.

Candida albicans: pathogenesis, immunity and host defence.

Ashman RB.

Res Immunol. 1998 May-Jun;149(4-5):281-8; discussion 494-6. Review. No abstract available.

PMID:
9720946
38.

Genetic determination of susceptibility and resistance in the pathogenesis of Candida albicans infection.

Ashman RB.

FEMS Immunol Med Microbiol. 1997 Nov;19(3):183-9. Review. No abstract available.

39.

In vivo evaluation of intramedullary interlocking nail fixation of transverse femoral osteotomies in foals.

McClure SR, Watkins JP, Ashman RB.

Vet Surg. 1998 Jan-Feb;27(1):29-36.

PMID:
9449175
40.
41.
42.

Three-dimensional computer analysis of complex acetabular insufficiency.

Roach JW, Hobatho MC, Baker KJ, Ashman RB.

J Pediatr Orthop. 1997 Mar-Apr;17(2):158-64.

PMID:
9075088
43.

Anatomical variation of human cancellous bone mechanical properties in vitro.

Hobatho MC, Rho JY, Ashman RB.

Stud Health Technol Inform. 1997;40:157-73.

PMID:
10168876
45.

Early inflammatory responses to Candida albicans infection in inbred and complement-deficient mice.

Fulurija A, Ashman RB, Papadimitriou JM.

FEMS Immunol Med Microbiol. 1996 Jun;14(2-3):83-94.

PMID:
8809543
47.

Intraosseous infusion of prostaglandin E2 prevents disuse-induced bone loss in the tibia.

Welch RD, Ashman RB, Baker KJ, Browne RH.

J Orthop Res. 1996 Mar;14(2):303-10.

PMID:
8648510
48.

Effects of anisotropy and material axis registration on computed stress and strain distributions in the turkey ulna.

Ricos V, Pedersen DR, Brown TD, Ashman RB, Rubin CT, Brand RA.

J Biomech. 1996 Feb;29(2):261-7.

PMID:
8849822
49.

Relationship of the virulence of Trichomonas vaginalis and the major histocompatibility complex in murine trichomonad infection.

Caterina P, Warton A, Papadimitriou JM, Ashman RB.

Parasitol Res. 1996;82(7):628-33.

PMID:
8875571
50.

Acute labyrinthitis associated with systemic Candida albicans infection in ageing mice.

Ashman RB, Papadimitriou JM, Fulurija A.

J Laryngol Otol. 1996 Jan;110(1):13-8.

PMID:
8745774

Supplemental Content

Loading ...
Support Center